NASDAQ : HAO
Haoxi Health Technology Limited — Key statistics
Communication Services · Advertising Agencies · China
Last price 1.92 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.22M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.22M |
| Enterprise Value | -8.10M |
Dates
| Measure | Value |
|---|
| Earnings Date | Sep 30, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 621,739 |
| Shares Outstanding | 637,634 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.51% |
| Owned by Institutions (%) | 0.47% |
| Float | 621,655 |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.02 |
| Forward PS | n/a |
| PB Ratio | 0.01 |
| P/TBV Ratio | 0.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.53 |
| Quick Ratio | 2.98 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -155.59 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -54.13% |
| Return on Assets (ROA) | -23.63% |
| Return on Invested Capital (ROIC) | -95.57% |
| Return on Capital Employed (ROCE) | -45.69% |
| Weighted Average Cost of Capital (WACC) | 0.94% |
| Revenue Per Employee | $1.96M |
| Profits Per Employee | -$340,580 |
| Employee Count | 28 |
| Asset Turnover | 2.54 |
| Inventory Turnover | 9.47 |
Taxes
| Measure | Value |
|---|
| Income Tax | 36,614 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -0.99 |
| 52-Week Price Change | -99.94% |
| 50-Day Moving Average | 2.68 |
| 200-Day Moving Average | 1,186.47 |
| Relative Strength Index (RSI) | 34.01 |
| Average Volume (20 Days) | 90,990 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 31,829 |
| Short Previous Month | 24,577 |
| Short % of Shares Out | 4.99% |
| Short % of Float | 5.12% |
| Short Ratio (days to cover) | 0.31 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 54.83M |
| Gross Profit | 629,090 |
| Operating Income | -8.16M |
| Pretax Income | -9.50M |
| Net Income | -9.54M |
| EBITDA | -7.85M |
| EBIT | -8.16M |
| Loss Per Share | -$386.40 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 10.93M |
| Total Debt | 1.61M |
| Net Cash | 9.32M |
| Net Cash Per Share | $14.62 |
| Equity (Book Value) | 17.86M |
| Book Value Per Share | 160.71 |
| Working Capital | 13.10M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -2.57M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 308,615 |
| Net Borrowing | -390,238 |
| Free Cash Flow | -2.57M |
| FCF Per Share | -$4.03 |
Margins
| Measure | Value |
|---|
| Gross Margin | 1.15% |
| Operating Margin | -14.88% |
| Pretax Margin | -17.33% |
| Profit Margin | -17.39% |
| EBITDA Margin | -14.32% |
| EBIT Margin | -14.88% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -20,125.00% |
| FCF Yield | -209.80% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 14, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 5.49 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |